The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.
MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
Morning Overview on MSN
Effort to end animal testing grows, but alternatives still fall short
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...
Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...
FDA and NIH recently announced initiatives outlining specific actions each agency will take to encourage greater adoption of new and emerging technologies to reduce the need for — and potentially ...
Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results